CA2207028A1 - Trousse pour cycle de traitement de l'osteoporose - Google Patents

Trousse pour cycle de traitement de l'osteoporose

Info

Publication number
CA2207028A1
CA2207028A1 CA002207028A CA2207028A CA2207028A1 CA 2207028 A1 CA2207028 A1 CA 2207028A1 CA 002207028 A CA002207028 A CA 002207028A CA 2207028 A CA2207028 A CA 2207028A CA 2207028 A1 CA2207028 A1 CA 2207028A1
Authority
CA
Canada
Prior art keywords
tiludronic acid
pharmaceutically acceptable
nutrient supplement
calcium
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002207028A
Other languages
English (en)
Inventor
Jacques Girard
Olivier Gros
Martine Gazard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2207028A1 publication Critical patent/CA2207028A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une trousse à utiliser dans un cycle thérapeutique basé sur l'administration séquentielle d'acide tiludronique ou d'un de ses sels et/ou solvates et de calcium pendant 28 à 31 jours, pour le traitement et/ou la prévention de l'ostéoporose.
CA002207028A 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose Abandoned CA2207028A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR94/14630 1994-12-06
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose

Publications (1)

Publication Number Publication Date
CA2207028A1 true CA2207028A1 (fr) 1996-06-13

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002207028A Abandoned CA2207028A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose

Country Status (20)

Country Link
EP (1) EP0797444A1 (fr)
JP (1) JPH10509729A (fr)
KR (1) KR980700083A (fr)
CN (1) CN1168634A (fr)
AR (1) AR002946A1 (fr)
AU (1) AU4307396A (fr)
BR (1) BR9509961A (fr)
CA (1) CA2207028A1 (fr)
CZ (1) CZ175397A3 (fr)
FI (1) FI972383A0 (fr)
FR (1) FR2727629A1 (fr)
HU (1) HUT77382A (fr)
IL (1) IL116168A0 (fr)
MA (1) MA23737A1 (fr)
NO (1) NO972558L (fr)
PL (1) PL320564A1 (fr)
SK (1) SK68597A3 (fr)
TR (1) TR199501530A1 (fr)
WO (1) WO1996017616A1 (fr)
ZA (1) ZA9510184B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
PT1506041E (pt) 2002-05-10 2007-12-28 Hoffmann La Roche Ácido ibandrónico para o tratamento e a prevenção da osteoporose
SI1790347T1 (sl) * 2002-12-20 2015-03-31 F. Hoffmann-La Roche Ag Formulacija z visokim odmerkom ibandronata

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114473T1 (de) * 1984-04-30 1994-12-15 Procter & Gamble Ausrüstung für die verwendung bei der behandlung von osteoporose.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
ATE161423T1 (de) * 1992-06-30 1998-01-15 Procter & Gamble Pharma Verwendung von phosphinate zur behandlung der osteoporose
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
ZA9510184B (en) 1996-06-11
FI972383A (fi) 1997-06-05
NO972558D0 (no) 1997-06-05
PL320564A1 (en) 1997-10-13
WO1996017616A1 (fr) 1996-06-13
BR9509961A (pt) 1997-11-25
MA23737A1 (fr) 1996-07-01
CZ175397A3 (en) 1997-10-15
HUT77382A (hu) 1998-04-28
AR002946A1 (es) 1998-05-27
MX9704105A (es) 1997-09-30
AU4307396A (en) 1996-06-26
SK68597A3 (en) 1997-11-05
NO972558L (no) 1997-08-05
JPH10509729A (ja) 1998-09-22
IL116168A0 (en) 1996-01-31
FI972383A0 (fi) 1997-06-05
EP0797444A1 (fr) 1997-10-01
FR2727629B1 (fr) 1997-02-28
FR2727629A1 (fr) 1996-06-07
CN1168634A (zh) 1997-12-24
TR199501530A1 (tr) 1996-10-21
KR980700083A (ko) 1998-03-30

Similar Documents

Publication Publication Date Title
Emmett et al. Calcium acetate control of serum phosphorus in hemodialysis patients
US20050026871A1 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
CA2454200A1 (fr) Formes posologiques pour la liberation gastrique immediate d'un stimulateur de transport du calcium et la liberation gastrique retardee d'un bis-phosphonate
US4861590A (en) Sustained release fluoride and calcium composition
US20170157001A1 (en) Compositions Comprising Strontium and Uses Thereof in the Treatment or Prevention of Gingivitis, Periodontitis, Periodontitis as a Manifestation of Systemic Diseases, and Necrotizing Periodontal Diseases
US4859467A (en) Sustained release fluoride composition
Birck et al. Calcium ketoglutarate versus calcium acetate for treatment of hyperphosphataemia in patients on maintenance haemodialysis: a cross-over study.
US5013728A (en) Composition for treating osteoporosis and hormonal imbalance
CA2671727C (fr) Composition contenant un acide bisphosphonique combine a de la vitamine d
CZ219798A3 (cs) Prostředek pro prevenci a léčbu osteoporézy
CA2207028A1 (fr) Trousse pour cycle de traitement de l'osteoporose
US4559326A (en) Antiinflammatory compositions and methods
EP1651191B1 (fr) Compositions pharmaceutiques effervescentes contenant de la vitamine d, du calcium et du phosphate et leur utilisation therapeutique
EP0521057A1 (fr) Compositions pharmaceutiques contenant de l'ipriflavone, procede de preparation et utilisations pharmaceutiques de ces compositions.
CA2294095C (fr) Compositions a effet synergique pour lutter selectivement contre les tissus tumoraux
MXPA97004105A (en) Set for use in a therapeutic treatment cycle of osteoporo
EP1661575A1 (fr) Utilisation de magnésium dans le traitement des troubles associés aux variations hormonales chez la femme
EP0268868A2 (fr) Compositions pharmaceutiques pour le traitement des maladies gastro-intestinales
JPH0840917A (ja) 向上した安全性側面を有する制酸薬調剤

Legal Events

Date Code Title Description
FZDE Discontinued